A latest prospective, longitudinal study measured the serum PD-L1 during pregnancy and postpartum in MS and the results showed that there was a trend of increased PD-L1 during the first trimester of pregnancy in patients without disease relapse, but did not achieve statistical significance [137]. This evidence concerns the gene CD274 and myeloid sarcoma.